02:53:53 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Global Cannabis Applications Corp
Symbol APP
Shares Issued 58,436,861
Close 2018-01-12 C$ 0.79
Market Cap C$ 46,165,120
Recent Sedar Documents

Global Cannabis joins Australian cannabis counsel

2018-01-12 14:11 ET - News Release

Mr. Bradley Moore reports

GLOBAL CANNABIS JOINS MEDICAL CANNABIS COUNSEL OF AUSTRALIA

Global Cannabis Applications Corp. has joined the Medical Cannabis Counsel of Australia as a premiere member. The counsel is an industry body, made up of health care professionals, researchers, medical cannabis producers and manufacturers, which develops best practices and standards for producing, supplying and distributing medical cannabis products in Australia.

"As an active participant in the emerging Australian medical cannabis industry, the Medical Cannabis Counsel is diligently working to engage government regarding related policies," said Jason Webb, managing director, GCAC Australian operations. "Our membership in the counsel will allow Global Cannabis to have a voice as we work to create a robust and dynamic medical cannabis industry to supply patients in Australia and around the world."

"With the Australian government's recent announcement to allow the export of medical cannabis and its goal of becoming a leading producer of medical cannabis worldwide, we join the prestigious Medical Cannabis Counsel at a very important time," said Brad Moore, chief executive officer of Global Cannabis. "The counsel has taken a pro-active approach with respect to the legalization of medical cannabis in Australia and I applaud the work they have done. I look forward to continuing the dialogue and working closely with the counsel as we roll out our Citizen Green data platform in Australia. As the market matures in Australia, we will be able to provide valuable insight into the development of the marketplace."

The Australia government has embraced the medical cannabis industry and is taking the necessary steps to establish a robust marketplace.

In November, 2016, the Australian Therapeutic Goods Administration (TGA) moved medical cannabis from a Schedule 9 to a Schedule 8 product, immediately creating a legal market for the sale and commercialization of medical cannabis in Australia. More recently, in January, 2018, the Australian government announced that it intends to remove the export ban on cannabis products in February, 2018, and allow the export of cannabis products worldwide.

When Australia officially becomes an exporter of medical cannabis it will join a select club -- only Canada, the Netherlands and Uruguay have legalized the export of medical cannabis. Israel intends to do so in the near future.

About the Medical Cannabis Counsel

The Medicinal Cannabis Council provides a unifying voice for the Australian medical cannabis industry. It provides a framework for best practice standards and support the Australian industry in becoming a world leader in the research and production of safe, high-quality, scientifically backed medical cannabis products.

About Global Cannabis Applications Corp.

Global Cannabis Applications is a global leader in designing, developing, marketing and acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world's first end-to-end -- from patient to regulator -- medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, reg tech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in medical cannabis.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.